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ABSTRACT
OBJECTIVE
To determine the effect of surgeon specific outcome 
reporting in colorectal cancer surgery on risk averse 
clinical practice, “gaming” of clinical data, and 90 day 
postoperative mortality.
DESIGN
National cohort study.
SETTING
English National Health Service hospital trusts.
POPULATION
111 431 patients diagnosed as having colorectal 
cancer from 1 April 2011 to 31 March 2015 included 
in the National Bowel Cancer Audit.
INTERVENTION
Public reporting of surgeon specific 90 day mortality 
in elective colorectal cancer surgery in England 
introduced in June 2013.
MAIN OUTCOME MEASURES
Proportion of patients with colorectal cancer who had 
an elective major resection, predicted 90 day mortality 
based on characteristics of patients and tumours, and 
observed 90 day mortality adjusted for differences in 
characteristics of patients and tumours, comparing 
patients who had surgery between April 2011 and 
June 2013 and between July 2013 and March 2015.
RESULTS
The proportion of patients with colorectal cancer 
undergoing major resection did not change after 
the introduction of surgeon specific public outcome 
reporting (39 792/62 854 (63.3%) before versus 
30 706/48 577 (63.2%) after; P=0.8). The proportion 
of these major resections categorised as elective 
or scheduled also did not change (33 638/39 792 
(84.5%) before versus 25 905/30 706 (84.4%) after; 
P=0.5). The predicted 90 day mortality remained the 
same (2.7% v 2.7%; P=0.3), but the observed 90 
day mortality fell (952/33 638 (2.8%) v 552/25 905 
(2.1%)). Change point analysis showed that this 
reduction was over and above the existing downward 
trend in mortality before the introduction of public 
outcome reporting (P=0.03).
CONCLUSIONS
This study did not find evidence that the introduction 
of public reporting of surgeon specific 90 day 
postoperative mortality in elective colorectal cancer 
surgery has led to risk averse clinical practice 
behaviour or “gaming” of data. However, its 
introduction coincided with a significant reduction in 
90 day mortality.
Introduction
In 2012 NHS England, the national body that 
coordinates the commissioning of health services 
in the English National Health Service (NHS), called 
for quality measures and mortality data to be made 
publicly available.1 In response, public reporting of 
named surgeon specific outcomes was introduced in 
June 2013 across nine surgical specialties, with the 
data being provided by pre-existing national clinical 
audits. Public reporting has now been extended to 
most surgical and some interventional specialties.
Since the reporting of surgeon specific outcomes 
was introduced in 2013, case numbers and risk 
adjusted 90 day mortality rates in patients undergoing 
an “elective” or “scheduled” major colorectal cancer 
resection have been reported for individual consultant 
colorectal surgeons. These rates are publicly available 
on the websites of the Association of Coloproctology of 
Great Britain and Ireland (ACPGBI) and NHS Choices.2 
The results are based on analyses of data provided 
by the National Bowel Cancer Audit (NBOCA).3 This 
national audit has been publishing surgical mortality 
results at hospital trust level in its annual reports 
since 2010.4
The publication of surgeon specific outcomes has 
been controversial.5-7 Proponents believe that surgeon 
specific outcome reporting facilitates transparency, 
allows patients to make informed choices, and may 
drive quality improvement.8 Critics argue that the 
potential professional and financial implications of 
the public reporting of perceived negative outcomes 
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WhAT IS AlReAdy knoWn on ThIS TopIC
Public reporting of outcomes at hospital level leads to increased quality 
improvement activity
The introduction of public reporting of individual surgeons’ outcomes has been 
controversial but has been studied only in cardiac surgery and almost exclusively 
in the US
Public reporting of outcomes is often criticised for encouraging risk averse 
behaviour and manipulation of data
WhAT ThIS STudy AddS
No evidence exists of risk averse clinical practice or “gaming” of data after the 
introduction of surgeon specific outcome reporting in elective colorectal cancer 
surgery in England
The introduction of surgeon specific outcome reporting coincided with a 
significant decrease in mortality, which exceeded the existing downward trend
Outcomes in patients having emergency surgery for bowel cancer did not 
change, suggesting improvement in preoperative preparation and planning of 
perioperative and postoperative care
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encourages risk averse behaviour, whereby surgeons 
are less likely to offer surgery to patients at higher risk. 
Data may also be manipulated to increase patients’ 
predicted risk or to make patients ineligible for public 
reporting, which is often referred to as “gaming.” So 
far, the evidence that reporting of surgeon specific 
outcome leads to improvements in the quality of 
patient care is surprisingly weak. The effect of public 
reporting of surgeon specific outcomes has been 
studied only in cardiac surgery, and these studies were 
almost exclusively carried out in the United States [8].
In this study, we analysed NBOCA data to look for 
evidence of risk averse behaviour, manipulation of 
data, and change in surgical mortality in the time 
period immediately before and after the introduction 
of surgeon specific outcome reporting in colorectal 
cancer surgery.
This is the first time that the effect of public reporting 
of surgeon specific outcomes has been presented 
outside cardiac surgery. Uniquely, we studied its 
effect on all patients with colorectal cancer diagnosed 
during the study period, irrespective of whether they 
underwent elective major surgery. In this way, we 
overcame a major limitation in all published studies 
to date that included only patients who had surgery 
and therefore could not assess the effect of risk averse 
behaviour and changes in patient selection.
Methods
Data collection and reporting of surgeon specific 
outcomes
NHS hospital trusts in England have a mandatory 
requirement to submit data for all patients with a 
new diagnosis of colorectal cancer via a secure online 
platform to the NBOCA database. Information is 
collected that captures surgical urgency (categorised as 
elective, scheduled, urgent, or emergency according to 
the National Confidential Enquiry into Patient Outcome 
and Death (NCEPOD) classification of intervention),9 
the American Society of Anesthesiologists (ASA) grade, 
pathological TNM staging, cancer site within the colon 
or rectum, and surgical procedure performed.
Data from NBOCA is linked to Hospital Episode 
Statistics (HES), the administrative database of all 
admissions to NHS hospitals in England. Information 
on admission type (elective or emergency), the 
formation of a stoma, and comorbidities is identified 
from these linked HES records. The Royal College of 
Surgeons’ Charlson score is used to identify comorbid 
conditions in the HES records in the preceding year.10 
The date of death is obtained from linked data from the 
Office for National Statistics (ONS).11
All elective or scheduled major colorectal cancer 
resections in patients aged 18 years and older at 
diagnosis, and listed under a consultant surgeon’s 
General Medical Council (GMC) code, are eligible for 
surgeon specific outcome reporting. This code is a 
unique identifier that is available for all clinicians 
registered with the GMC, the body that maintains the 
official register of medical practitioners in the UK.12 
In the UK, a consultant surgeon is a surgeon who has 
completed all his or her specialist training and has 
been placed on the GMC’s Specialist Register.
Reports of the eligible patients are sent to the NHS 
hospital trusts, which allows them to check the data 
before analysis. Hospital trusts are notified of observed 
and adjusted 90 day mortality rates at the level of both 
the surgeon and the trust before publication. Surgeons’ 
outcomes are not published individually for surgeons 
who have carried out fewer than 10 major cancer 
resections within the reporting period.
Study population and outcome measures
We included in this study patients submitted to the 
NBOCA dataset and diagnosed as having primary 
colorectal cancer from 1 April 2011 to 31 March 2015. 
The quality of NBOCA data improved considerably from 
1 April 2011, which was why we chose this start date. 
Data collection for metastatic disease was changed 
from Dukes’ stage to M stage in 2013. This change 
corresponded with a drop in data completeness.
Risk aversion in bowel cancer surgery may manifest 
as surgeons becoming less willing to offer patients 
a surgical resection, especially patients deemed to 
be at higher risk. In addition, surgeons may be more 
likely to refer patients to hospital trusts deemed to 
be more specialised. Also, in treating rectal cancer, 
surgeons may be more inclined to offer patients a 
surgical procedure associated with lesser morbidity 
and mortality, such as performing a defunctioning 
stoma at the time of anterior resection or preferentially 
performing an abdominoperineal excision of rectum 
or Hartmann’s procedure over restoring intestinal 
continuity. Surgeons may also be more disposed 
to offer minimally invasive procedures, such as 
endoscopic mucosal resection or transanal endoscopic 
microsurgery (which are not included in public 
reporting).
To investigate risk averse behaviour, we therefore 
studied the overall rate of major resection, the 
characteristics of patients undergoing major resection 
and their tumours, the predicted 90 day mortality 
according to characteristics of patients and tumours, 
the proportion of patients undergoing surgery at a 
different hospital trust from the one at which their 
tumour was diagnosed, and the type of treatment in 
patients with rectal cancer. We compared all of these 
before and after the introduction of public reporting of 
outcomes.
The deliberate manipulation, or gaming, of data may 
manifest in data submitted to the audit that is more 
“subjective” in nature, including the classification of 
surgical urgency and ASA grade. Gaming of surgical 
urgency data may result in an increase in the number 
of patients who had elective surgery being reclassified 
as “urgent” or “emergency,” and therefore recorded 
as ineligible for surgeon specific outcome reporting. 
Of the nine variables included in the risk adjustment 
score for 90 day mortality,13 only ASA grade can be 
considered subjective. Consequently, a tendency 
may exist to report higher ASA grades in patients 
undergoing elective surgery, which would lead to 
RESEARCH
the bmj | BMJ 2018;361:k1581 | doi: 10.1136/bmj.k1581 3
higher predicted surgical 90 day mortality and, in 
turn, a lower overall adjusted mortality. To assess 
for evidence of gaming of data, we compared the 
proportion of patients undergoing major resection who 
were classified as urgent or emergency (and therefore 
ineligible for surgeon specific outcome reporting) and 
the ASA grade recorded in patients undergoing elective 
major resection, before and after the introduction of 
surgeon specific outcome reporting.
To determine the effect of surgeon specific outcome 
reporting on outcomes for patients eligible for 
inclusion in public outcome reporting, we compared 
the observed 90 day postoperative mortality without 
and with adjustment for characteristics of patients and 
tumours in patients undergoing elective or scheduled 
major resection. We included patients ineligible for 
public outcome reporting as comparison groups. For 
this purpose, we studied the observed and adjusted 
90 day postoperative mortality for patients undergoing 
urgent or emergency major resection and the observed 
six month survival after diagnosis of patients not 
undergoing major resection. We chose a longer analysis 
period of six months after diagnosis for these patients 
to reflect the fact that most would not undergo surgery 
and would have received palliative management.
Statistical analysis
The risk adjustment model used by NBOCA was 
developed and validated previously.13 The risk factors 
included in this logistic regression model are age, 
sex, ASA grade, Charlson comorbidity score, mode of 
admission, site of tumour, and pathological T stage, 
N stage, and M stage, with an additional interaction 
between age and M stage. We modelled a random 
intercept for each hospital trust to reflect the possible 
clustering of results within trusts. Missing values for 
the risk factors were imputed with multiple imputation 
using chained equations creating 10 datasets and 
using Rubin’s rules to combine the model estimates 
across the datasets. An adjusted outcome was then 
produced by indirect standardisation.14 We compared 
proportions before and after the introduction of public 
reporting with a χ2 test, median age with the Kruskal-
Wallis test, and differences in predicted 90 day 
mortality with a t test.
We used a change point analysis to study the change 
over time in adjusted 90 day mortality after elective/
scheduled major resection (eligible for surgeon specific 
outcome reporting) and after urgent/emergency major 
resection (ineligible for surgeon specific outcome 
reporting).15 The change point was fixed to the date of 
the introduction of surgeon specific outcome reporting 
(28 June 2013). We used a multivariable logistic 
regression model for 90 day mortality, with a slope 
for calendar time and an interaction between time 
pre-introduction versus post-introduction of surgeon 
specific outcome reporting, in addition to all of the 
risk adjustment variables. This modelled a change in 
the slope of mortality at the point that surgeon specific 
outcome reporting was introduced but no immediate 
change in mortality.
As a sensitivity analysis, we fitted two further change 
point models to the same data. The first modelled 
an immediate shift in mortality at the introduction 
of surgeon specific outcome reporting by including 
a term for before and after the introduction of public 
reporting. The second modelled both an immediate 
shift and a change in the slope. We used Stata version 
14.1 for all analyses.
Patient involvement
No patients were involved in setting the research 
question or the outcome measures, nor were they 
involved in developing plans for recruitment, design, 
or implementation of the study. No patients were asked 
to advise on interpretation or writing up of results. The 
results of this research will be publicly disseminated 
via the National Bowel Cancer Audit website as well as 
through the charity and patient representatives who 
act as part of the audit’s Clinical Advisory Group.
Results
Risk averse behaviour
We identified 111 431 patients diagnosed as having 
colorectal cancer during the study period. Of the 
62 854 patients who received a diagnosis before the 
introduction of public reporting, 39 792 (63.3%) 
had a major resection, and this was the case for 
30 706 (63.2%) of the 48 577 patients who received a 
diagnosis thereafter (P=0.8) (fig 1).
The characteristics of the 33 638 patients who 
had an elective or scheduled major resection before 
the introduction of public reporting and the 25 905 
patients who had one afterwards differed little 
(table 1). The proportion of patients with metastatic 
disease decreased from 9.6% before to 7.2% after 
the introduction (P<0.001). The mean predicted 90 
day mortality based on characteristics of patients 
and tumours did not change (2.7% before and 2.7% 
after the introduction of public reporting; P=0.3) 
(fig 2). The proportion of patients undergoing surgical 
resection at a different hospital trust from where they 
were given a diagnosis slightly reduced; 1981/33 638 
(5.9%) patients given a diagnosis before introduction 
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Fig 1 | Proportion of patients undergoing major resection 
according to date of diagnosis. Dotted line represents 
date of introduction of surgeon specific public outcome 
reporting
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and 1401/25 905 (5.4%) patients given a diagnosis 
afterwards were treated in a different hospital (P=0.01).
We found no evidence of a change in the care 
received by patients with rectal cancer. Of the 18 700 
patients diagnosed as having rectal cancer before the 
introduction of public reporting, 1274 (6.8%) had 
a local excision compared with 1012 (7.0%) of the 
14 457 diagnosed after the introduction (P=0.6). Of 
the rectal cancer patients undergoing major resection, 
no increase occurred in the proportion of patients 
undergoing procedures with no primary anastomosis 
(Hartmann’s procedure or abdominoperineal 
excision of rectum) with the introduction of surgeon 
specific outcome reporting (3410/10 206 (33.4%) 
before and 2735/7871 (34.7%) after; P=0.06). 
The proportion of patients with rectal cancer 
undergoing anterior resection with the addition of a 
defunctioning stoma was 4748/6430 (73.8%) before 
introduction compared with 3466/4788 (72.4%) 
after introduction (P=0.09).
Gaming of data
We found no evidence of gaming of data (fig 3). The 
proportion of major resections categorised as urgent 
or emergency—and therefore ineligible for surgeon 
specific outcome reporting—did not change, as 6154 
(15.5%) of 39 792 major resections were categorised 
as urgent or emergency before and 4801 (15.6%) 
of 30 706 major resections after the introduction of 
public reporting (P=0.5). The distribution of ASA 
grades did not change before and after introduction 
(P=0.08) (table 1).
Mortality in patients eligible for inclusion in 
surgeon specific outcome reporting
The 90 day mortality in patients undergoing an 
elective or scheduled major resection fell during 
the study period from 952/33 638 (2.8%) before the 
Table 1 | Clinico-pathological characteristics of patients undergoing elective or scheduled major resection from 1 
April 2011 to 31 March 2015 according to year of surgery. Values are numbers (percentages) unless stated otherwise
Characteristics
Before public outcome  
reporting (n=33 638)
After public outcome  
reporting (n=25 905) Total (n=59 543) P value
Male sex 19 504 (58.0) 14 807 (57.2) 34 311 (57.6) 0.04
Median (IQR) age, years 70 (62-78) 70 (62-78) 70 (62-78) 0.6
ASA grade:
 1 4410 (14.0) 3481 (14.1) 7891 (14.1)
0.08
 2 18 263 (58.0) 14 524 (58.9) 32 787 (58.4)
 3 8202 (26.1) 6247 (25.3) 14 449 (25.7)
 4/5 597 (1.9) 426 (1.7) 1023 (1.8)
 Missing 2166 1227 3393
Charlson comorbidity score:
 0 23 053 (70.2) 16 748 (67.5) 39 801 (69.0)
<0.001 1 7397 (22.5) 5874 (23.7) 13 271 (23.0) 2 2397 (7.3) 2191 (8.8) 4588 (8.0)
 Missing 791 1092 1883
T stage:
 0 534 (1.6) 496 (1.9) 1030 (1.8)
0.03
 1 2516 (7.7) 1879 (7.3) 4395 (7.5)
 2 6046 (18.4) 4791 (18.7) 10 837 (18.5)
 3 17 652 (53.8) 13 733 (53.6) 31 385 (53.7)
 4 6075 (18.5) 4724 (18.4) 10 799 (18.5)
 Missing 815 282 1097
N stage:
 0 20 012 (61.0) 15 849 (61.9) 35 861 (61.4)
0.09 1 8190 (25.0) 6275 (24.5) 14 465 (24.8) 2 4620 (14.1) 3502 (13.7) 8122 (13.9)
 Missing 816 279 1095
M stage:
 0 29 398 (90.5) 21 498 (92.8) 50 896 (91.4)
<0.001 1 3103 (9.6) 1668 (7.2) 4771 (8.6)
 Missing 1137 2739 3876
Referred to alternative trust for surgery 1981 (5.9) 1401 (5.4) 3382 (5.7) 0.01
ASA=American Society of Anesthesiologists; IQR=interquartile range.
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Fig 2 | Predicted 90 day mortality for elective and 
scheduled major resection according to date of surgery. 
Dotted line represents date of introduction of surgeon 
specific public outcome reporting
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introduction of surgeon specific outcome reporting 
to 552/25 905 (2.1%) after (fig 4). Therefore, we 
carried out change point analysis which showed 
a steeper decline in 90 day mortality after the 
introduction of public reporting (P=0.03). The 
change point analysis also found a significant effect 
of public reporting when it was modelled as an 
immediate shift in 90 day mortality (P=0.01) and 
when it was modelled as both an immediate shift 
and a change in slope (P=0.04).
Mortality in patients not eligible for inclusion in 
surgeon specific outcome reporting
We saw no change in the slope of 90 day mortality in 
patients undergoing urgent or emergency surgery with 
the introduction of surgeon specific outcome reporting 
(941/6154 (15.3%) before and 749/4801 (15.6%) 
after; P=0.3) (fig 5). The six month mortality of patients 
not undergoing major resection remained static over 
the study period; 7514/23 062 (32.6%) had died six 
months after diagnosis before the introduction of 
surgeon specific outcome reporting and 5728/17 871 
(32.1%) after, as shown in figure 6.
discussion
This study, using data from a high profile, national 
service evaluation project, found no evidence that the 
introduction of surgeon specific public reporting of 90 
day mortality after elective colorectal surgery has led to 
risk averse behaviour or gaming of data in the English 
NHS. The proportion of patients undergoing major 
resection, the proportion of these patients potentially 
eligible for outcome reporting, and the predicted 
risk in those undergoing major resection remained 
the same. However, the introduction of the public 
reporting of outcomes coincided with a reduction in 
the 90 day mortality, exceeding the existing downward 
trend, in patients who were included in the outcome 
reporting programme—namely, those patients who 
had an elective or scheduled major resection. No 
effect on mortality was seen in patients who were 
not included—colorectal cancer patients who had an 
urgent or emergency major resection or those who did 
not have a major resection—showing that outcomes in 
these groups were not negatively affected.
Strengths and weaknesses of study
This is the first study to evaluate the effect of the public 
reporting of surgeons’ outcomes in gastrointestinal 
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Fig 3 | Proportion of major resections classified as urgent 
or emergency (therefore ineligible for surgeon specific 
outcome reporting) according to date of diagnosis. 
Dotted line represents date of introduction of surgeon 
specific public outcome reporting
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Fig 5 | Observed and adjusted mortality in patients 
undergoing urgent or emergency major resection 
according to date of surgery. Dotted line represents date of 
introduction of surgeon specific public outcome reporting
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Fig 6 | Observed six month mortality (from diagnosis) 
in patients not undergoing major resection. Dotted line 
represents date of introduction of surgeon specific public 
outcome reporting
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Fig 4 | Observed and adjusted mortality in patients 
undergoing elective or scheduled major resection 
according to date of surgery. Dotted line represents 
date of introduction of surgeon specific public outcome 
reporting
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surgery. Previous studies assessing the effect of public 
reporting of surgeon specific outcomes were limited to 
cardiac surgery.16-19 It is also the first study to compare 
the effect of surgeon specific outcome reporting on 
all patients with a specific diagnosis, rather than 
only those undergoing a specific procedure, so that 
the effect of risk aversive behaviour and selection of 
patients could also be studied.
We identified more than 111 000 patients who had 
colorectal cancer in a national database, almost 60 000 
of whom had undergone an elective major resection. 
This group represents 92% of all colorectal cancer 
patients admitted to an English NHS hospital.3 This 
national coverage and the high “case ascertainment” 
reduces the risk of selection bias.
Clinicians had little opportunity to manipulate the 
outcome data. We obtained mortality data through 
record linkage with death records provided by the Office 
for National Statistics. Other clinical data were entered 
by audit staff from patients’ records. Clinical teams 
have a role in this process, but surgeons themselves 
do not have individual access rights to enter or edit the 
data themselves. Nevertheless, it is conceivable that 
a patient’s operative urgency could retrospectively be 
changed from “scheduled” to “urgent,” which would 
make the patient ineligible for outcome reporting, or 
that a patient’s ASA grade could be increased, which 
would decrease the 90 mortality adjusted for patients’ 
risk factors. However, we were able to examine whether 
the data entered for patients diagnosed as having 
colorectal cancer up until June 2013 had changed 
after the introduction of outcome reporting, and we 
found no difference in the distribution of reported ASA 
grades or the number of patients undergoing elective 
or scheduled major resection.
In studies using a “before-after” design, changes 
may occur over time in the quality of the data and 
in clinical factors that may have an effect on the 
study results. We tried to overcome this limitation by 
rigorously checking differences in the accuracy and 
completeness of the data as part of our assessment 
of possible gaming of data before and after the 
introduction of public reporting. Also, we aimed 
to overcome differences in patients’ characteristics 
through adjustment for possible differences in the 
risk profile of patients who had surgery before and 
after the introduction of public reporting, on the 
basis of a previously published validated prognostic 
model.13 Lastly, we used change point modelling to 
take into account the fact that outcomes of colorectal 
cancer surgery are gradually improving over time. We 
found that the introduction of public reporting had a 
significant effect on surgical mortality, irrespective of 
whether this effect was modelled as a change in the 
slope (representing a faster decrease in mortality after 
the introduction of public reporting), an immediate 
shift in mortality, or a combination of these effects.
Risk averse behaviour
The use of risk adjustment methods that adequately 
ensure that providers who treat patients at higher risk 
are not unfairly penalised is critical in public reporting 
of surgical outcomes for several reasons. Firstly, if 
surgeons do not fully accept the accuracy of these 
methods, they may be more inclined to avoid carrying 
out major surgical procedures in patients at higher 
risk.20 A recent survey conducted across 293 English 
colorectal surgeons asking about their views on 
surgeon specific outcome reporting found that almost 
all had concerns about the possibility that it could 
lead to colleagues avoiding operating on patients at 
high risk.21 These concerns are not supported by the 
results of our study. For example, we found no change 
in the expected mortality risk before and after the 
introduction of public reporting of mortality outcomes.
Evidence of risk averse behaviour after the 
introduction of surgeon specific outcome reporting is 
mixed in cardiac surgery. Patients undergoing cardiac 
bypass procedures in states in America with public 
reporting of outcomes were found to have lower illness 
severity than patients in states that did not publicly 
release such data.22 In contrast, in the UK, the average 
predicted mortality of patients undergoing cardiac 
surgery seemed to increase rather than decrease in the 
years immediately after the introduction of surgeon 
specific outcome reporting.17
Although the overall risk of patients undergoing 
elective colorectal cancer resection was unchanged 
across the study period, the proportion of patients 
undergoing primary resection with metastatic disease 
was slightly reduced. Recent population based studies 
carried out in the US and in Europe found a similar 
decrease in the percentage of metastatic colorectal 
cancer patients undergoing primary tumour resection, 
which suggests that this decrease reflects an overall 
change in practice rather than risk averse behaviour.23 24
Gaming of data
Manipulation of data has been reported in studies 
investigating the effect of public reporting of individual 
surgeons’ outcomes. A study carried out in the 1990s 
evaluating the effect of surgeon specific outcome 
reporting in New York State found that about 40% of 
the reduction in risk adjusted mortality from coronary 
artery bypass grafting could be explained by the 
gaming of data, either as a result of an increase in risk 
factor coding or a change in definitions.25
To reduce the possible effect of deliberately increases 
in the ASA grade recorded for a patient, the Association 
of Coloproctology of Great Britain and Ireland has 
recommended that the ASA grade of each patient 
should be determined by the anaesthetist rather than 
by the surgeon and that this grade should be recorded 
before the resection of the cancer.26 This may in part 
explain why we did not observe any change in the 
proportion of patients with higher ASA grades among 
patients undergoing an elective major resection after 
the introduction of public surgeon specific reporting.
Mortality
The introduction of surgeon specific outcome reporting 
coincided with a decrease in mortality after elective 
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major colorectal cancer surgery over and above the pre-
existing downward trend in mortality. This study did 
not show a similar reduction in mortality in patients 
undergoing emergency colorectal cancer resection 
after the introduction of surgeon specific public 
outcome reporting. This suggests that changes to 
preoperative preparation and planning of perioperative 
and postoperative care—for example, through the 
implementation of programmes aiming to enhance 
recovery after surgery27—may have contributed to the 
improved mortality rate we have shown. Preoperative 
cardiopulmonary exercise testing, which can only be 
implemented in patients who undergo an elective or 
scheduled procedure, may have led to changes in the 
delivery of postoperative care, such as the increased 
use of level 2 and level 3 beds in patients at high 
risk.28 29 Rather than resulting in risk aversion, public 
reporting of outcomes may have focused attention on 
an individual patient’s risk and ways of minimising 
that risk.
Technical aspects of the surgical procedure are 
unlikely to have improved dramatically over the study 
period, but it is certainly conceivable that the focus 
on individual consultant surgeons’ practice may have 
indirectly led to greater involvement of surgeons in the 
patients’ actual preoperative and postoperative care, 
with more proactive management of complications. 
Surgical trainees have also highlighted that 
public reporting of outcomes has reduced training 
opportunities in patients eligible for public reporting.7
Effect of public reporting of surgeon specific 
outcome data
It has been argued that public reporting of outcomes 
for hospitals or clinicians can have many uses.30 
Firstly, it may facilitate patient choice in selecting a 
specific hospital or clinician that seems to have better 
outcomes. Evidence from several countries such as the 
UK, the US, and the Netherlands shows that younger 
and more affluent patients are more likely to have 
their treatment in other hospitals than the one closest 
to where they live.31 Secondly, outcome data may 
influence decisions of purchasers or commissioners of 
health services either with the aim of controlling costs 
or to obtain the best outcomes within a limited budget. 
Thirdly, regulators of healthcare services, such as the 
Care Quality Commission in England, can consider 
reported outcomes when they monitor the quality 
and safety of care delivered by individual providers. 
Finally, hospitals and clinicians can use the outcomes 
to assess the performance of their organisation or their 
individual staff members when implementing quality 
improvement initiatives.
The outcomes of surgeons performing fewer than 10 
elective or scheduled major resection cases a year are 
not reported in the public domain, but the outcomes 
for these patients are included in this analysis. 
Although it is feasible that due to surgeon specific 
outcome reporting the number of surgeons performing 
the occasional resection has decreased, therefore 
resulting in improved outcomes for patients, we have 
not seen this reflected in NBOCA data—the proportion 
of elective or scheduled cases by surgeons performing 
fewer than 10 major resection a year has remained 
constant (5.0% pre-outcome reporting, 5.2% post-
outcome reporting).
We found a drop in mortality of patients who had 
elective colorectal surgery immediately after the 
introduction of surgeon specific public outcome 
reporting. This immediacy of the effect suggests a direct 
response by the hospitals and clinicians themselves 
rather than a more indirect response prompted 
by choices that patients make or by actions from 
purchasers or regulators. Similarly, although other 
major improvements in care of patients with colorectal 
cancer have been made during the study period, such 
as advances in chemotherapy, these changes are more 
likely to affect overall survival rather than specifically 
90 day postoperative mortality in patients having 
elective and scheduled surgery.
However, surgical outcomes are influenced by many 
organisational factors, and an individual surgeon’s 
results may therefore merely be a “surrogate reflection” 
of the hospital’s overall performance.32 Also, the 
number of bowel cancer procedures that a bowel 
cancer surgeon does each year is low, as is the power to 
detect a surgeon who is performing poorly. Previously, 
we have argued that a major risk of public reporting of 
individual surgeons’ outcomes is that it could lead to 
false complacency.33
What general lessons can be learnt from these 
results? If we assume that the decrease in mortality 
can be causally linked to the reporting or individual 
surgeons’ outcomes, the process of reporting itself 
rather than a response to particular outcomes may 
have triggered a change in how patients who are 
scheduled to have major colorectal cancer surgery are 
managed, not only by the surgeon but by the entire 
team responsible for a patient’s care, which could 
be considered as a manifestation of the Hawthorne 
effect.34 This team response could have been mediated 
through an individual surgeon’s “heightened 
responsibility,” which in turn may have galvanised 
the entire team involved in managing patients before, 
during, and after elective bowel cancer surgery.
This interpretation provides a more nuanced position 
in the debate about whether outcome results should 
be published for clinicians or for teams or hospitals. A 
further consideration is that the specific circumstances of 
elective surgery may also play a role, given the emerging 
evidence for the effectiveness of enhanced recovery 
programmes and cardiopulmonary exercise testing, 
which provide possible routes to improve outcomes of 
patients undergoing scheduled procedures.35 In this 
context, an increase in the use of radiotherapy before 
surgery could also play a role for patients with rectal 
cancer. Unfortunately, we do not have evidence on 
increases in the use of radiotherapy over time.36
Conclusions
In an era of ongoing “assessment and accountability,”37 
consultant colorectal cancer surgeons who practise 
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in the English NHS have an obligation to engage with 
individual public outcome reporting. The potential 
positive and negative consequences of public reporting 
are widely speculated on but are largely unexplored.30 
This national study provides unique evidence that 
the introduction of public reporting of outcomes for 
individual colorectal cancer surgeons has not led 
to a decrease in the number of patients at high risk 
undergoing a major resection and has coincided with an 
improvement in 90 day mortality for eligible patients.
Public reporting of outcomes for individual 
clinicians seems to have triggered an improvement 
in outcomes after elective procedures that can be 
achieved only through the involvement of the entire 
clinical team. We did not find similar improvements 
in the outcome of emergency procedures. This points 
to improved preoperative preparation and planning of 
perioperative and postoperative care, only possible for 
elective procedures, as a potential possible explanation 
for the reduction in surgical mortality.
Hospital Episode Statistics data were made available by NHS Digital.
Contributors: AEV conceived and designed the study, analysed the 
data, and drafted and revised the paper. AK prepared and analysed 
the data. JH designed the study and drafted and revised the paper. 
NSF conceived and designed the study, interpreted the results, and 
drafted and revised the paper. CM-A drafted and revised the paper. 
MB designed the study and drafted and revised the paper. JvdM 
designed the study, interpreted the results, and drafted and revised 
the paper. KW designed the study, analysed the data, and drafted 
and revised the paper. All authors, external and internal, had full 
access to all of the data (including statistical reports and tables) in the 
study and can take responsibility for the integrity of the data and the 
accuracy of the data analysis. JvdM is the guarantor.
Funding: The National Bowel Cancer Audit is commissioned by 
the Healthcare Quality Improvement Partnership (HQIP) as part of 
the National Clinical Audit and Patient Outcomes Programme, and 
funded by NHS England and the Welsh Government (www.hqip.
org.uk/national-programmes). Neither HQIP nor the funders had 
any involvement in the study design; in the collection, analysis, 
and interpretation of data; in the writing of the report; or in the 
decision to submit the article for publication. The researchers 
had full independence from the Healthcare Quality Improvement 
Partnership.
Competing interests: All authors have completed the ICMJE uniform 
disclosure form at www.icmje.org/coi_disclosure.pdf (available on 
request from the corresponding author) and declare: no support from 
any organisation for the submitted work; no financial relationships 
with any organisations that might have an interest in the submitted 
work in the previous three years; no other relationships or activities 
that could appear to have influenced the submitted work.
Ethical approval: As the National Bowel Cancer Audit involves 
analysis of data for service evaluation, it is exempt from the UK 
National Research Ethics Committee approval. Section 251 approval 
was obtained from the Ethics and Confidentiality Committee for the 
collection of the personal health data.
Transparency declaration: The lead author (AEV) affirms that the 
manuscript is an honest, accurate, and transparent account of the 
study being reported; that no important aspects of the study have 
been omitted; and that any discrepancies from the study as planned 
(and, if relevant, registered) have been explained.
Data sharing: No additional data available.
This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this work 
non-commercially, and license their derivative works on different 
terms, provided the original work is properly cited and the use is non-
commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
1 England NHS. Everyone counts: planning for patients 2013/14. 
2012. https://www.england.nhs.uk/everyonecounts/.
2 Choices NHS. Consultants specialising in colorectal cancer surgery 
in England. 2017. https://www.nhs.uk/service-search/consultants/
performanceindicators/1030.
3 Digital NHS. National Bowel Cancer Audit. http://content.digital.nhs.
uk/bowel.
4 National Bowel Cancer Audit. Reports. nboca.org.uk.
5 Moonesinghe  SR. Individualised surgical outcomes: please look 
the other way. Postgrad Med J 2013;89:677-8. doi:10.1136/
postgradmedj-2013-132442 
6 Khajuria  A. Public reporting of surgeon outcomes in the United 
Kingdom: potential caveats. Int J Surg 2014;12:369-70. 
doi:10.1016/j.ijsu.2014.02.001 
7 Radford  PD, Derbyshire  LF, Shalhoub  J, Fitzgerald  JE, Council of the 
Association of Surgeons in Training. Publication of surgeon specific 
outcome data: a review of implementation, controversies and the 
potential impact on surgical training. Int J Surg 2015;13:211-6. 
doi:10.1016/j.ijsu.2014.11.049 
8 Alderson  D, Cromwell  D. Publication of surgeon-specific outcomes. 
Br J Surg 2014;101:1335-7. doi:10.1002/bjs.9641 
9 National Confidential Enquiry into Patient Outcome and Death. The 
NCEPOD Classification of Intervention. 2004. http://www.ncepod.org.
uk/classification.html.
10 Armitage  JN, van der Meulen  JHRoyal College of Surgeons Co-
morbidity Consensus Group. Identifying co-morbidity in surgical 
patients using administrative data with the Royal College of Surgeons 
Charlson Score. Br J Surg 2010;97:772-81. doi:10.1002/bjs.6930 
11 Office for National Statistics. Deaths registered in England and Wales. 
2014. https://www.ons.gov.uk/peoplepopulationandcommunity/
birthsdeathsandmarriages/deaths/bulletins/
deathsregistrationsummarytables/2015-07-15.
12 NHS Classifications Service. OPCS Classifications of Interventions and 
Procedures Version 4.4. Department of Health, 2007.
13 Walker  K, Finan  PJ, van der Meulen  JH. Model for risk adjustment 
of postoperative mortality in patients with colorectal cancer. Br J 
Surg 2015;102:269-80. doi:10.1002/bjs.9696 
14 Spiegelhalter  DJ. Funnel plots for comparing 
institutional performance. Stat Med 2005;24:1185-202. 
doi:10.1002/sim.1970 
15 Chen  J, Gupta  AK. Parametric statistical change point analysis: with 
applications to genetics, medicine, and finance. Springer Science & 
Business Media, 2011.
16 Hannan  EL, Kilburn  H Jr, Racz  M, Shields  E, Chassin  MR. 
Improving the outcomes of coronary artery bypass surgery 
in New York State. JAMA 1994;271:761-6. doi:10.1001/
jama.1994.03510340051033 
17 Bridgewater  B, Grayson  AD, Brooks  N, et al, North West Quality 
Improvement Programme in Cardiac Interventions. Has the 
publication of cardiac surgery outcome data been associated with 
changes in practice in northwest England: an analysis of 25,730 
patients undergoing CABG surgery under 30 surgeons over eight 
years. Heart 2007;93:744-8. doi:10.1136/hrt.2006.106393 
18 Khan  OA, Iyengar  S, Pontefract  DE, Rogers  V, Ohri  SK, 
Livesey  SA. Impact of surgeon-specific data reporting on 
surgical training. Ann R Coll Surg Engl 2007;89:796-8. 
doi:10.1308/003588407X232080 
19 Li  Z, Carlisle  DM, Marcin  JP, et al. Impact of public reporting 
on access to coronary artery bypass surgery: the California 
Outcomes Reporting Program. Ann Thorac Surg 2010;89:1131-8. 
doi:10.1016/j.athoracsur.2009.12.073 
20 Resnic  FS, Welt  FGP. The public health hazards of risk avoidance 
associated with public reporting of risk-adjusted outcomes 
in coronary intervention. J Am Coll Cardiol 2009;53:825-30. 
doi:10.1016/j.jacc.2008.11.034 
21 Penna  M, Moran  B, Crane  S, Hompes  R, Cunningham  C. Surgeon-
specific outcome reporting: is it time to move forward? Colorectal 
Dis 2016;18:1031-2. doi:10.1111/codi.13433 
22 Dranove  D, Kessler  D, McClellan  M, Satterthwaite  M. Is More 
Information Better? The Effects of “Report Cards” on Health Care 
Providers. J Polit Econ 2003;111:555-88. doi:10.1086/374180.
23 Tarantino  I, Warschkow  R, Worni  M, et al. Prognostic Relevance of 
Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal 
Cancer Patients: A Population-Based, Propensity Score-Adjusted 
Trend Analysis. Ann Surg 2015;262:112-20. doi:10.1097/
SLA.0000000000000860 
24 van der Geest  LG, Lam-Boer  J, Koopman  M, Verhoef  C, Elferink  MA, 
de Wilt  JH. Nationwide trends in incidence, treatment and survival 
of colorectal cancer patients with synchronous metastases. Clin Exp 
Metastasis 2015;32:457-65. doi:10.1007/s10585-015-9719-0 
25 Green  J, Wintfeld  N. Report cards on cardiac surgeons. Assessing 
New York State’s approach. N Engl J Med 1995;332:1229-32. 
doi:10.1056/NEJM199505043321812 
26 NHS Digital. National Bowel Cancer Audit (NBOCA) frequently asked 
questions. 2017. http://content.digital.nhs.uk/media/17324/
NBOCAFAQs-2017/pdf/NBOCA_FAQs2017_v1.0.pdf.
RESEARCH
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
27 Ljungqvist  O, Scott  M, Fearon  KC. Enhanced Recovery After 
Surgery: A Review. JAMA Surg 2017;152:292-8. doi:10.1001/
jamasurg.2016.4952 
28 West  MA, Parry  MG, Lythgoe  D, et al. 
Cardiopulmonary exercise testing for the prediction of morbidity 
risk after rectal cancer surgery. Br J Surg 2014;101:1166-72. 
doi:10.1002/bjs.9551 
29 West  MA, Lythgoe  D, Barben  CP, et al. Cardiopulmonary 
exercise variables are associated with postoperative 
morbidity after major colonic surgery: a prospective blinded 
observational study. Br J Anaesth 2014;112:665-71. doi:10.1093/
bja/aet408 
30 Marshall  MN, Shekelle  PG, Leatherman  S, Brook  RH. The public 
release of performance data: what do we expect to gain? A 
review of the evidence. JAMA 2000;283:1866-74. doi:10.1001/
jama.283.14.1866 
31 Aggarwal  A, Lewis  D, Mason  M, Sullivan  R, van 
der Meulen  J. Patient Mobility for Elective Secondary 
Health Care Services in Response to Patient Choice Policies: 
A Systematic Review. Med Care Res Rev 2017;74:379-403. 
doi:10.1177/1077558716654631 
32 Ergina  PL, Cook  JA, Blazeby  JM, et al, Balliol Collaboration. 
Challenges in evaluating surgical innovation. 
Lancet 2009;374:1097-104. doi:10.1016/S0140-
6736(09)61086-2 
33 Wallace  D, Walker  K, Kuryba  A, Finan  P, Scott  N, van der Meulen  
J. Identifying patients at risk of emergency admission for colorectal 
cancer. Br J Cancer 2014;111:577-80. doi:10.1038/bjc.2014.300 
34 Braunholtz  DA, Edwards  SJ, Lilford  RJ. Are randomized clinical 
trials good for us (in the short term)? Evidence for a “trial 
effect”. J Clin Epidemiol 2001;54:217-24. doi:10.1016/S0895-
4356(00)00305-X 
35 Moran  J, Wilson  F, Guinan  E, McCormick  P, Hussey  J, Moriarty  J. 
Role of cardiopulmonary exercise testing as a risk-assessment 
method in patients undergoing intra-abdominal surgery: a 
systematic review. Br J Anaesth 2016;116:177-91. doi:10.1093/
bja/aev454 
36 National Bowel Cancer Audit. Report 2016. 2016. https://www.
nboca.org.uk/reports/annual-report-2016/.
37 Relman  AS. Assessment and accountability: the third revolution 
in medical care. N Engl J Med 1988;319:1220-2. doi:10.1056/
NEJM198811033191810 
